Nashiah

Capability

MLR & OPDP Risk Readiness

Reduce review risk and accelerate compliant execution.

Schedule an Executive AI Strategy Session
Solutions MLR & OPDP Risk Readiness

The challenge

Why this matters

MLR bottlenecks delay launches, campaign updates, safety updates, HCP materials, and digital assets — and sensitive content cannot flow through unmanaged AI tools.

What we do

How Nashiah helps

MLR-ready execution workflows

Build readiness earlier in the process.

Pre-MLR readiness checks

Catch issues before formal review.

Claims & reference readiness

Organize claims and references for smooth review.

Compliance checkpoints

MLR and compliance gates embedded in workflows.

Governed AI for sensitive content

Keep MLR-sensitive content in managed environments.

Our AI supports MLR review processes and does not replace required approvals.

How we do it

We build MLR-ready workflows earlier in the process — extracting claims, matching them to approved references, and running pre-review checks so submissions arrive cleaner and more consistent.

Why it matters

MLR bottlenecks delay launches and campaign updates. Preparing assets before review reduces avoidable rework and improves first-pass quality — while approvals remain firmly with your reviewers.

Pre-MLR intelligence

See the issue before the review cycle does.

Nashiah detects claims, maps them to approved evidence, explains potential risk, and prepares a cleaner asset for human review.

Detect the claimIdentify promotional language in context.
Connect the evidenceMatch references and approved claims.
Explain the riskSurface what is supported and what is not.
Prepare for reviewProduce an evidence-linked, review-ready asset.
NOVAHEALTH™
HCP Digital Detail Aid · Draft 03
Demonstration only
Not for promotional use

A more confident path to sustained disease control

In a 24-week controlled study, NovaHealth demonstrated across the primary efficacy endpoint.

Clinical improvement was observed , with benefit maintained through Week 24.

NovaHealth is administered according to the approved prescribing information.

References: Study NH-204 Clinical Study Report · Prescribing Information · Approved Claims Library v6.2

Illustrative demonstration. Nashiah supports MLR review and never replaces required approvals.

Outcomes

Business value

  • Faster, lower-risk content and campaign execution
  • Fewer avoidable review-cycle issues
  • Confident handling of regulated content

Unlock the full value of the Veeva AI ecosystem

Move beyond isolated AI pilots and build a governed, scalable operating model that connects Veeva, commercial operations, content, data, analytics, and enterprise AI.

Schedule an Executive AI Strategy Session